Case series assessing pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy
Latest Information Update: 09 Feb 2022
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Progressive multifocal leukoencephalopathy
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 09 Feb 2022 New trial record
- 01 Feb 2022 Results published in the Journal of Neurology